Cargando…
Statistical Assessment of Drug Synergy from In Vivo Combination Studies Using Mouse Tumor Models
Drug combination therapy is a promising strategy for treating cancer; however, its efficacy and synergy require rigorous evaluation in preclinical studies before going to clinical trials. Existing methods have limited power to detect synergy in animal studies. Here, we introduce a novel approach to...
Autores principales: | Mao, Binchen, Guo, Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591909/ https://www.ncbi.nlm.nih.gov/pubmed/37830749 http://dx.doi.org/10.1158/2767-9764.CRC-23-0243 |
Ejemplares similares
-
The design, analysis and application of mouse clinical trials in oncology drug development
por: Guo, Sheng, et al.
Publicado: (2019) -
Statistical assessment and visualization of synergies for large-scale sparse drug combination datasets
por: Amzallag, Arnaud, et al.
Publicado: (2019) -
Mouse Stromal Cells Confound Proteomic Characterization and Quantification of Xenograft Models
por: Shi, Zhaomei, et al.
Publicado: (2023) -
Statistical determination of synergy based on Bliss definition of drugs independence
por: Demidenko, Eugene, et al.
Publicado: (2019) -
Pharmacometrics meets statistics—A synergy for modern drug development
por: Ryeznik, Yevgen, et al.
Publicado: (2021)